Maintaining Outstanding Outcomes Using Response- and Biology-Based Therapy for Intermediate-Risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531.

Bibliographic Details
Title: Maintaining Outstanding Outcomes Using Response- and Biology-Based Therapy for Intermediate-Risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531.
Authors: Twist, Clare J., Schmidt, Mary Lou, Naranjo, Arlene, London, Wendy B., Tenney, Sheena C., Marachelian, Araz, Shimada, Hiroyuki, Collins, Margaret H., Esiashvili, Natia, Adkins, E. Stanton, Mattei, Peter, Handler, Michael, Katzenstein, Howard, Attiyeh, Edward, Hogarty, Michael D., Gastier-Foster, Julie, Wagner, Elizabeth, Matthay, Katherine K., Park, Julie R., Maris, John M.
Source: Journal of Clinical Oncology; 12/1/2019, Vol. 37 Issue 34, p3243-3255, 21p
Database: Supplemental Index
More Details
ISSN:0732183X
DOI:10.1200/JCO.19.00919
Published in:Journal of Clinical Oncology
Language:English